Classification (Agonist/Antagonist) and Regression “Structure-Activity” Models of Drug Interaction with 5-HT6

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 18, Iss. 3, 2018-12 ,pp. : 213-221

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies for Design of Non Peptide CCK1R Agonist/Antagonist Ligands

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 12, 2007-06 ,pp. : 1180-1194

Bentham Science Publishers

Access to resources Recommend Favorite

Structure and pharmacology of 4,5,6,7-tetrahydroisothiazolo[5,4-c]pyridin-3-ol (Thio-THIP), an agonist/antagonist at GABA A receptors

By Brehm L.   Ebert B.   Kristiansen U.   Wafford K.   Kemp J.   Krogsgaard-Larsen P.  

European Journal of Medicinal Chemistry, Vol. 32, Iss. 4, 1997-01 ,pp. : 357-363

Elsevier

Access to resources Recommend Favorite

Agonist-antagonist characterization of 6'-cyanohex-2'-yne- 8 -tetrahydrocannabinol in two isolated tissue preparations

By Pertwee R.G.   Fernando S.R.   Griffin G.   Ryan W.   Razdan R.K.   Compton D.R.   Martin B.R.  

European Journal of Pharmacology, Vol. 315, Iss. 2, 1996-11 ,pp. : 195-201

Elsevier

Access to resources Recommend Favorite

The 1 -adrenoceptor agonist, SDZ NVI-085, behaves as a potent, competitive antagonist of 5-hydroxytryptamine-induced contraction of rat aorta

By Van der Graaf P.H.   Apaydin S.   Saxena P.R.  

European Journal of Pharmacology, Vol. 287, Iss. 3, 1995-12 ,pp. : 309-312

Elsevier

Access to resources Recommend Favorite